Johnson & Johnson plans to see its DePuy Synthes orthopedics unit depart in the middle of next year, while it faces global ...
Olympus received an FDA warning letter over quality management systems used at six facilities in Japan, Germany and the U.S.
Stryker netted exclusive U.S. rights to sell CMR's Versius robot, while pocketing an option to acquire the company in the ...
Medtronic remains No. 1, but an innovation focus is enabling medtechs such as Abbott and Intuitive to move up our list of ...
Below are five proven startup CEOs on how they intentionally design for access — building healthcare access into their ...
BD (Becton, Dickinson and Co.) (NYSE: BDX) has promoted from within for the new worldwide president of its Surgery business ...
Rhevera Medical represents a clear commitment to the physicians who take on difficult vascular cases and to the patients who ...
Edwards Lifesciences’ Autus size-adjustable heart valve [Illustration courtesy of Edwards Lifesciences] Edwards Lifesciences ...
Boston Scientific will split its cardiovascular group into Interventional Therapies and Rhythm Solutions, and promote Joe ...
AFib-treating cardiac ablation has been a standout performer for Medtronic, with strong commercial demand for the Affera ...
Kevin Lobo is ending a more than 14-year tenure that saw him guide Stryker through dozens of acquisitions that helped the ...
Masimo sought prejudgement interest covering the time Apple would have made a royalty agreement for its blood oxygen sensor ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results